Orchestra BioMed Inc.

NASDAQ: OBIO · Real-Time Price · USD
2.56
-0.10 (-3.76%)
At close: Aug 15, 2025, 3:59 PM
2.57
0.19%
After-hours: Aug 15, 2025, 07:58 PM EDT

Orchestra BioMed Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
22.26M 30.56M 19.78M 9.94M
Short-Term Investments
44.55M 57.04M 64M 958K
Long-Term Investments
2.5M 2.5M 2.5M 398K
Other Long-Term Assets
1.02M 769K 4.71M 690K
Receivables
92K 99K 96K 121K
Inventory
173K 146K 276K 68K
Other Current Assets
2.09M 1.27M n/a n/a
Total Current Assets
69.17M 89.11M 84.69M 11.32M
Property-Plant & Equipment
3.49M 2.83M 3.68M 1.12M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
7M 6.1M 10.88M 2.21M
Total Assets
76.17M 95.21M 95.57M 13.53M
Account Payables
5.13M 2.9M 3.97M 2.03M
Deferred Revenue
4.44M 2.51M 6.44M 5.54M
Short-Term Debt
550K n/a 697K 2M
Other Current Liabilities
2.06M 2.66M 4.29M 780K
Total Current Liabilities
16.21M 11.21M 18.57M 12.24M
Long-Term Debt
14.29M n/a 9.49M 3.67M
Other Long-Term Liabilities
40K 14.92M 196K 51.99M
Total Long-Term Liabilities
27.01M 15.96M 24.47M 72.52M
Total Liabilities
43.22M 27.17M 43.04M 84.76M
Total Debt
16.53M 1.69M 11.87M 5.67M
Common Stock
4K 4K 2K 160M
Retained Earnings
-309.88M -248.85M -199.73M -166.13M
Comprehensive Income
52K -10K -8K -211.45M
Shareholders Equity
32.96M 68.04M 52.53M -71.23M
Total Investments
47.05M 59.53M 66.5M 1.36M